Alternative Treatments for Apprehensive DED Patients November 20, 2023 With patient apprehension from OTC eye drop recalls, James Deom, OD, leads with education first, followed by safe and proven in-office
Itay Mayer, VP and Managing Director of Lumenis Vision, shares exciting product updates about OptiLight 2.0 and insights into Lumenis’ consumer campaign at VEE 2023
Itay Mayer, Vice President and Managing Director of Lumenis Vision, caught up with Optometry Times® to share an update on the company and its products, which was showcased during the 2023 Vision Expo East meeting in New York, New York.
Lumenis to Be Acquired for Approximately $510 Million, $14.00 per Share, in Cash
Lumenis Ltd. (NASDAQ: LMNS), the world’s largest energy-based medical company for surgical, ophthalmology and aesthetic applications, announced today that it has signed a definitive agreement to be acquired by XIO Group for $14.00 per share in cash, for an aggregate purchase price of approximately $510 million.
Smart532
Smart 532™ is the newest photocoagulator by Lumenis, enhanced with SmartPulse™ sub-threshold technology.
Ge et al. (2020): Evaluation of the efficacy of optimal pulsed technology treatment in patients with cataract and Meibomian gland dysfunction in the perioperative period
In a prospective, comparative study, Lumenis IPL with OPT™ improved signs and symptoms of mild to moderate MGD in patients who underwent cataract surgery.
Perioperative IPL to Prevent and Improve Symptoms of Post Laser Corneal Refractive Surgery Dry Eye
Clinical StudiesDry Eye Perioperative IPL to Prevent and Improve Symptoms of Post Laser Corneal Refractive Surgery Dry Eye February 26, 2024 In a randomized controlled study of subjects undergoing corneal
SLT for Glaucoma
We invite you to learn about the eye disease and the importance of regular eye exams, proper diagnosis, and appropriate treatment options in managing glaucoma and preserving vision.
OptiLIFT in Action: Dr. Julie McLaughlin’s Experience with the New Device
Press PublicationsDry EyePeriorbital Muscle Stimulation OptiLIFT in Action: Dr. Julie McLaughlin’s Experience with the New Device April 28, 2025 Julie McLaughlin, OD ABO Diplomate Ocular Surface Disease (Dry Eye Syndrome)
Doubling Down on Innovation: Why Dr. Nikki Iravani Invested in Two OptiLIFT Systems
Dr. Nikki Iravani chose to bring OptiLIFT into both of her eyeXam practices. She highlights strong patient interest, the simplicity of the treatment, and the visible aesthetic improvements it provides. OptiLIFT fits into her broader effort to expand her offerings beyond traditional eye exams into wellness and aesthetics.
Lumenis Features Acoustics & Heat Experience and Introduces PicoFractional™ Technology at the American Academy of Dermatology Annual Meeting (AAD)
Lumenis Ltd., the world’s largest energy-based medical device company for aesthetic, surgical, and ophthalmic applications, is thrilled to unveil Pico Fractional™, a new photoacoustic fractional laser, at the American Academy of Dermatology (AAD) Annual Meeting in San Diego, CA from February 16th-18th, 2018.